yet these agents may favor an increase of lean mass and mimic an energy deprivation state with increased ketogenesis (i.e., BHB) through increased circulating GH levels ( Figure 1 )
In this review, we summarize current evidence supporting the existence of glutamate abnormalities in OCD, and we assess the potential utility of these glutamate-modulating pharmacological strategies in the treatment of refractory disease
These tools help address the gaps between confidence and knowledge that the survey revealed by translating scientific evidence into simple, actionable steps
To view a copy of this licence, visit About this article Cite this article Moss, D.Y., Brown, C.N., Shaw, A.M
Precise measurement is essential not only for cost-effectiveness but also for ensuring therapeutic efficacy and minimizing systemic toxicity